Pure Biologics Spólka Akcyjna
PUR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | -100% | -85.6% | 160.6% | – |
| Gross Profit | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | -2,709.5% | -816.8% | -1,585.4% |
| EBITDA | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | -27,449.5% | -3,440.6% | -3,392.9% |
| Net Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | -37,572.6% | -3,983.7% | -5,146.1% |
| EPS Diluted | -3.78 | -11.19 | -11.87 | -5.88 |
| % Growth | 66.2% | 5.7% | -101.9% | – |
| Operating Cash Flow | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Capital Expenditures | PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |